Stocks like Revance Therapeutics Inc. [RVNC] still have plenty of sunny days ahead

Stocks of Revance Therapeutics Inc. (NASDAQ:RVNC) traded higher last session on Wall Street, down -0.65% to $24.60. According to the data, Revance Therapeutics Inc. (NASDAQ:RVNC) has 12 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $65.00 and […]